tiprankstipranks
Akoya Biosciences (AKYA)
NASDAQ:AKYA
US Market

Akoya Biosciences (AKYA) Financial Statements

127 Followers

Akoya Biosciences Financial Overview

Akoya Biosciences's market cap is currently ―. The company's EPS TTM is $-1.473; its P/E ratio is -1.64; Akoya Biosciences is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 18.35M$ 26.49M$ 25.21M$ 23.52M$ 21.41M
Gross Profit$ 8.38M$ 22.65M$ 21.48M$ 23.52M$ 12.29M
EBIT$ -23.39M$ -10.79M$ -12.86M$ -20.74M$ -17.48M
EBITDA$ -21.67M$ -8.49M-$ -18.47M$ -15.51M
Net Income Common Stockholders$ -23.48M$ -10.80M$ -12.92M$ -20.80M$ -18.80M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 61.58M$ 83.13M$ 78.59M$ 93.33M$ 60.25M
Total Assets$ 154.75M$ 180.37M$ 177.24M$ 188.88M$ 154.30M
Total Debt$ 85.19M$ 85.71M$ 75.07M$ 75.67M$ 75.28M
Net Debt$ 23.61M$ 2.58M$ -3.52M$ -17.66M$ 15.03M
Total Liabilities$ 122.03M$ 126.60M$ 115.27M$ 116.98M$ 112.17M
Stockholders Equity$ 32.72M$ 53.77M$ 61.97M$ 71.90M$ 42.12M
Cash Flow-
Free Cash Flow$ -21.63M$ -6.18M-$ -13.76M$ -20.79M
Operating Cash Flow$ -20.82M$ -5.58M$ -13.75M$ -12.33M$ -19.98M
Investing Cash Flow$ -48.82M$ -594.00K$ -832.00K$ -893.00K$ 6.42M
Financing Cash Flow$ -444.00K$ 11.08M$ -141.00K$ 46.33M$ -419.00K
Currency in USD

Akoya Biosciences Earnings and Revenue History

Akoya Biosciences Debt to Assets

Akoya Biosciences Cash Flow

Akoya Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis